Neurocrine Biosciences IncNASDAQ:NBIX
- LAST PRICE116.4900
- TODAY'S CHANGE (%)-1.2600 (-1.0701%)
- Bid / Lots113.0100/ 1
- Ask / Lots117.5000/ 1
- Open / Previous Close117.8900 / 117.7500
- Day Range
- 52 Week Range
- Volume881,985
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NBIX |
|---|---|---|
| 09:32 ET | 5665 | 117.38 |
| 09:34 ET | 250 | 117.404 |
| 09:36 ET | 6029 | 117.49 |
| 09:38 ET | 11267 | 117.485 |
| 09:39 ET | 300 | 117.39 |
| 09:41 ET | 100 | 117.535 |
| 09:43 ET | 1625 | 117.475 |
| 09:45 ET | 1535 | 117.235 |
| 09:48 ET | 1325 | 117.25 |
| 09:50 ET | 1300 | 117.05 |
| 09:52 ET | 1700 | 117 |
| 09:54 ET | 900 | 117.015 |
| 09:56 ET | 625 | 116.9 |
| 09:57 ET | 1175 | 116.85 |
| 09:59 ET | 2010 | 117.16 |
| 10:01 ET | 200 | 117.42 |
| 10:03 ET | 2248 | 117.32 |
| 10:06 ET | 1120 | 117.41 |
| 10:08 ET | 400 | 117.46 |
| 10:10 ET | 600 | 117.365 |
| 10:12 ET | 500 | 117.46 |
| 10:14 ET | 3710 | 117.09 |
| 10:15 ET | 700 | 116.945 |
| 10:17 ET | 505 | 117.12 |
| 10:19 ET | 600 | 117.235 |
| 10:21 ET | 6536 | 116.82 |
| 10:24 ET | 5309 | 117.005 |
| 10:26 ET | 300 | 117.005 |
| 10:28 ET | 2552 | 116.8 |
| 10:30 ET | 1057 | 116.6 |
| 10:32 ET | 500 | 116.55 |
| 10:33 ET | 3767 | 116.59 |
| 10:35 ET | 938 | 116.56 |
| 10:37 ET | 1297 | 116.52 |
| 10:39 ET | 1000 | 116.44 |
| 10:42 ET | 600 | 116.47 |
| 10:44 ET | 343 | 116.47 |
| 10:46 ET | 500 | 116.47 |
| 10:48 ET | 2486 | 116.59 |
| 10:50 ET | 853 | 116.535 |
| 10:51 ET | 500 | 116.555 |
| 10:53 ET | 400 | 116.46 |
| 10:55 ET | 821 | 116.555 |
| 10:57 ET | 18814 | 116.3 |
| 11:00 ET | 4857 | 116.45 |
| 11:02 ET | 400 | 116.495 |
| 11:04 ET | 900 | 116.37 |
| 11:06 ET | 801 | 116.47 |
| 11:08 ET | 1409 | 116.635 |
| 11:09 ET | 200 | 116.64 |
| 11:11 ET | 540 | 116.61 |
| 11:13 ET | 1230 | 116.67 |
| 11:15 ET | 400 | 116.52 |
| 11:18 ET | 401 | 116.7 |
| 11:20 ET | 500 | 116.715 |
| 11:22 ET | 1300 | 116.685 |
| 11:24 ET | 2899 | 116.655 |
| 11:26 ET | 2722 | 116.625 |
| 11:27 ET | 400 | 116.71 |
| 11:31 ET | 419 | 116.725 |
| 11:33 ET | 3408 | 116.87 |
| 11:36 ET | 540 | 116.895 |
| 11:38 ET | 1325 | 116.97 |
| 11:40 ET | 200 | 116.975 |
| 11:42 ET | 829 | 116.955 |
| 11:44 ET | 1261 | 116.9 |
| 11:45 ET | 3177 | 116.875 |
| 11:47 ET | 200 | 116.8 |
| 11:49 ET | 1000 | 116.78 |
| 11:51 ET | 100 | 116.77 |
| 11:54 ET | 1400 | 116.9 |
| 11:56 ET | 300 | 116.835 |
| 11:58 ET | 2244 | 116.8525 |
| 12:00 ET | 4938 | 116.925 |
| 12:02 ET | 700 | 116.915 |
| 12:03 ET | 600 | 116.915 |
| 12:05 ET | 386 | 116.95 |
| 12:07 ET | 400 | 116.955 |
| 12:09 ET | 1131 | 116.93 |
| 12:12 ET | 500 | 116.96 |
| 12:14 ET | 200 | 116.965 |
| 12:16 ET | 1452 | 116.965 |
| 12:18 ET | 1750 | 116.89 |
| 12:20 ET | 900 | 116.845 |
| 12:21 ET | 100 | 116.8 |
| 12:23 ET | 4130 | 116.84 |
| 12:25 ET | 1000 | 116.795 |
| 12:27 ET | 100 | 116.795 |
| 12:30 ET | 1506 | 116.78 |
| 12:32 ET | 300 | 116.78 |
| 12:34 ET | 4825 | 116.775 |
| 12:36 ET | 400 | 116.765 |
| 12:38 ET | 3245 | 116.765 |
| 12:39 ET | 300 | 116.77 |
| 12:41 ET | 1845 | 116.95 |
| 12:43 ET | 7243 | 116.88 |
| 12:45 ET | 1000 | 116.86 |
| 12:48 ET | 600 | 116.81 |
| 12:50 ET | 999 | 116.8 |
| 12:52 ET | 100 | 116.805 |
| 12:54 ET | 2415 | 116.72 |
| 12:56 ET | 200 | 116.72 |
| 12:59 ET | 558 | 116.735 |
| 01:01 ET | 1400 | 116.6 |
| 01:03 ET | 4036 | 116.77 |
| 01:06 ET | 249 | 116.79 |
| 01:08 ET | 908 | 116.73 |
| 01:10 ET | 200 | 116.73 |
| 01:12 ET | 777 | 116.69 |
| 01:14 ET | 300 | 116.725 |
| 01:15 ET | 4100 | 116.73 |
| 01:17 ET | 400 | 116.73 |
| 01:19 ET | 100 | 116.72 |
| 01:21 ET | 2500 | 116.7 |
| 01:24 ET | 1704 | 116.715 |
| 01:26 ET | 409 | 116.715 |
| 01:28 ET | 510 | 116.735 |
| 01:30 ET | 600 | 116.715 |
| 01:32 ET | 1006 | 116.68 |
| 01:33 ET | 599 | 116.685 |
| 01:35 ET | 2948 | 116.71 |
| 01:37 ET | 287 | 116.715 |
| 01:39 ET | 716 | 116.715 |
| 01:42 ET | 960 | 116.72 |
| 01:44 ET | 600 | 116.715 |
| 01:46 ET | 8390 | 116.7764 |
| 01:48 ET | 1501 | 116.76 |
| 01:50 ET | 4100 | 116.775 |
| 01:51 ET | 854 | 116.78 |
| 01:53 ET | 1900 | 116.75 |
| 01:55 ET | 5410 | 116.795 |
| 01:57 ET | 1300 | 116.795 |
| 02:00 ET | 9126 | 116.65 |
| 02:02 ET | 4978 | 116.585 |
| 02:04 ET | 2120 | 116.56 |
| 02:06 ET | 5180 | 116.6 |
| 02:08 ET | 6503 | 116.575 |
| 02:09 ET | 400 | 116.575 |
| 02:11 ET | 200 | 116.575 |
| 02:13 ET | 1400 | 116.65 |
| 02:15 ET | 1100 | 116.58 |
| 02:18 ET | 4070 | 116.51 |
| 02:20 ET | 1026 | 116.52 |
| 02:22 ET | 899 | 116.57 |
| 02:24 ET | 300 | 116.52 |
| 02:26 ET | 850 | 116.61 |
| 02:27 ET | 4200 | 116.575 |
| 02:29 ET | 300 | 116.545 |
| 02:31 ET | 1725 | 116.48 |
| 02:33 ET | 1597 | 116.53 |
| 02:36 ET | 717 | 116.545 |
| 02:38 ET | 4931 | 116.485 |
| 02:40 ET | 400 | 116.49 |
| 02:42 ET | 2156 | 116.465 |
| 02:44 ET | 2610 | 116.38 |
| 02:45 ET | 434 | 116.28 |
| 02:47 ET | 3647 | 116.28 |
| 02:49 ET | 100 | 116.315 |
| 02:51 ET | 1600 | 116.34 |
| 02:54 ET | 200 | 116.345 |
| 02:56 ET | 2300 | 116.27 |
| 02:58 ET | 1318 | 116.31 |
| 03:02 ET | 200 | 116.26 |
| 03:03 ET | 5643 | 116.4 |
| 03:05 ET | 700 | 116.73 |
| 03:07 ET | 500 | 116.74 |
| 03:09 ET | 200 | 116.7 |
| 03:12 ET | 1922 | 116.7452 |
| 03:14 ET | 400 | 116.785 |
| 03:16 ET | 3000 | 116.735 |
| 03:18 ET | 2315 | 116.82 |
| 03:20 ET | 5107 | 116.83 |
| 03:21 ET | 511 | 116.795 |
| 03:23 ET | 7167 | 116.8 |
| 03:25 ET | 2634 | 116.67 |
| 03:27 ET | 1127 | 116.75 |
| 03:30 ET | 2460 | 116.82 |
| 03:32 ET | 2948 | 116.76 |
| 03:34 ET | 2514 | 116.71 |
| 03:36 ET | 2100 | 116.62 |
| 03:38 ET | 1014 | 116.58 |
| 03:39 ET | 3074 | 116.79 |
| 03:41 ET | 1500 | 116.74 |
| 03:43 ET | 3184 | 116.69 |
| 03:45 ET | 44245 | 116.37 |
| 03:48 ET | 2200 | 116.45 |
| 03:50 ET | 2200 | 116.58 |
| 03:52 ET | 5040 | 116.56 |
| 03:54 ET | 4758 | 116.53 |
| 03:56 ET | 9488 | 116.785 |
| 03:57 ET | 17459 | 116.37 |
| 03:59 ET | 187257 | 116.49 |
Sep 19, 2024
Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
Sep 16, 2024
DJ Neurocrine Price Target Maintained With a $155.00/Share by Cantor Fitzgerald, from 12:31PM ET on Monday Sep 16, 2024 by Dow Jones
12:31PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
DJ Neurocrine Biosciences's Schizophrenia Treatment Misses Endpoint, from 4:33PM ET on Thursday Sep 12, 2024 by Dow Jones
4:33PM ET on Thursday Sep 12, 2024 by Dow JonesNeurocrine Biosciences Provides Update on ERUDITE(TM) Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia, from 4:05PM ET on Thursday Sep 12, 2024 by Dow Jones
4:05PM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 10, 2024
Neurocrine Biosciences to Participate at the 2024 Cantor Global Healthcare Conference, from 4:01PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:01PM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neurocrine Biosciences Inc | 11.9B | 35.2x | +62.04% |
Medpace Holdings Inc | 11.2B | 33.5x | +35.10% |
Qiagen NV | 10.0B | 141.0x | +12.66% |
Sarepta Therapeutics Inc | 11.9B | 301.1x | --- |
Exelixis Inc | 7.5B | 22.5x | -21.77% |
Biomarin Pharmaceutical Inc | 13.2B | 52.4x | --- |
Company Information
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.
Contact Information
- Headquarters
- 6027 EDGEWOOD BEND COURTSAN DIEGO, CA, United States 92130
- Phone
- 858-617-7600
- Fax
- 858-617-7602
Executives
- Non-Executive Independent Chairman of the Board
- William Rastetter
- Director
- Kevin Gorman
- Chief Financial Officer
- Matthew Abernethy
- Chief Human Resource Officer
- Julie Cooke
- Chief Scientific Officer
- Jude Onyia
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.9B |
|---|---|
Revenue (TTM) | $2.1B |
Shares Outstanding | 101.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $3.31 |
Book Value | $22.61 |
P/E Ratio | 35.2x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | 32.7x |
Operating Margin | 25.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
